Archer
Lv1
40 积分
2023-11-16 加入
-
Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial
2天前
已完结
-
Safety and efficacy of vesatolimod (GS-9620) in patients with chronic hepatitis B who are not currently on antiviral treatment
10天前
已完结
-
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
11天前
已完结
-
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
13天前
已完结
-
Cancer incidence and mortality in China, 2022
1个月前
已完结
-
[Cancer statistics in China, 2016]
1个月前
已完结
-
Targets and future direct-acting antiviral approaches to achieve hepatitis B virus cure
2个月前
已完结
-
Roadmap to functional cure of chronic hepatitis B: An expert consensus
2个月前
已完结
-
Efficacy and safety of fitusiran prophylaxis in people with haemophilia A or haemophilia B with inhibitors (ATLAS-INH): a multicentre, open-label, randomised phase 3 trial
3个月前
已完结
-
Fitusiran prophylaxis in people with severe haemophilia A or haemophilia B without inhibitors (ATLAS-A/B): a multicentre, open-label, randomised, phase 3 trial
3个月前
已完结